Basic research

American Society for Laser Medicine and Surgery Hosts its 43rd Annual Conference

Retrieved on: 
Monday, December 18, 2023
Ignition, Translation, Basic research, Baltimore Convention Center, Engineering, Medicine, Nursing, Conference, Plasma, Science, Surgeon, National Ignition Facility, LLLT, Machine, MBA, Doctor of Philosophy, Society, Physician, Health, Dentistry, MSCI, Laser, MD

WAUSAU, Wis., Dec. 18, 2023 /PRNewswire-PRWeb/ -- The American Society for Laser Medicine and Surgery (ASLMS) is regarded as the top international society for the exchange of information on medical laser and energy-based technologies. 2024 marks the 43rd year of the Annual Conference of the ASLMS.

Key Points: 
  • WAUSAU, Wis., Dec. 18, 2023 /PRNewswire-PRWeb/ -- The American Society for Laser Medicine and Surgery (ASLMS) is regarded as the top international society for the exchange of information on medical laser and energy-based technologies.
  • 2024 marks the 43rd year of the Annual Conference of the ASLMS.
  • ASLMS is a unique society where people from many specialties in clinical medicine come together with scientists and engineers to explore energy-based technologies to improve patient care.
  • The American Society for Laser Medicine and Surgery, Inc. (ASLMS) is the largest multi-disciplinary professional organization dedicated to the development and application of lasers and related technology for health care applications.

Susan G. Komen® Breast Cancer Research Awards Presented To Exceptional Breast Cancer Physician Scientists And Research Advocate

Retrieved on: 
Wednesday, December 6, 2023
Woman, Walter, Global Health, Liver cancer, Ron Link (patient advocate), Patient, Research, Radiation therapy, Funding of science, Prognosis, Cancer, Oncology, Doctor of Philosophy, Recurrence, Quality of life, Vanderbilt University Medical Center, University, Division, Dana–Farber Cancer Institute, MBBS, Harvard Medical School, Genetics, FACP, SAN, Breast cancer, Dean (education), Clinical research, Mentorship, Survivor, University of Chicago, Liquid biopsy, Associate, Disease, Flexner Report, Internal medicine, MPH, Neoplasm, Birth control, Medical imaging, Dietary supplement, Pharmaceutical industry, Science, Basic research, Medicine, MD

SAN ANTONIO, Dec. 6, 2023 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, will present awards to four dedicated physician scientists and a pioneering research advocate for their work to drive discoveries and improve breast cancer patient outcomes. They will be recognized tonight at the Susan G. Komen Breast Cancer Research Awards event in San Antonio.

Key Points: 
  • SAN ANTONIO, Dec. 6, 2023 /PRNewswire/ -- Susan G. Komen ®, the world's leading breast cancer organization, will present awards to four dedicated physician scientists and a pioneering research advocate for their work to drive discoveries and improve breast cancer patient outcomes.
  • They will be recognized tonight at the Susan G. Komen Breast Cancer Research Awards event in San Antonio.
  • This evening's awardees have made significant contributions in breast cancer research and clinical practice, both of which are critical to fighting this disease.
  • They have advanced our understanding of the mechanisms underlying the genesis of breast cancer (Basic Science) and have pioneered advances in breast cancer care (Clinical Research).

THERESA'S RESEARCH FOUNDATION ANNOUNCES NEW WHITE PAPER AND CELEBRATES 10 YEARS OF BRINGING CANCER RESEARCHERS AND PATIENT ADVOCATES TOGETHER

Retrieved on: 
Monday, August 21, 2023
Steps, Linda, Mayo Clinic, University, Education, Friends, Accidental Death and Disability: The Neglected Disease of Modern Society, White paper, Johns Hopkins School of Medicine, Metastatic breast cancer, Cancer, Research, Doctor of Philosophy, Alvin J. Siteman Cancer Center, University of Utah, Basic research, Huntsman Cancer Institute, Professor, Patient, Breast cancer, Baylor College of Medicine, Odds, Friends of Cancer Research, Family, Conference, Nursing, Birth control, Pharmaceutical industry

This White Paper highlights Findings from the 2022 Metastatic Breast Cancer Research Conference and is a follow up to our publication in npj Breast Cancer .

Key Points: 
  • This White Paper highlights Findings from the 2022 Metastatic Breast Cancer Research Conference and is a follow up to our publication in npj Breast Cancer .
  • "Patient advocates and cancer researchers working together is critical for better research that leads to improved patient outcomes.
  • "I'm thrilled to welcome so many outstanding breast cancer researchers from across the world to the 10th annual Metastatic Breast Cancer Research Conference.
  • The Foundation will host a celebration to mark its 10-year milestone at this year's Metastatic Breast Cancer Research Conference in Park City, Utah on August 31.

University of Medicine and Health Sciences Presents "Pathways to Practicing Medicine in Puerto Rico"

Retrieved on: 
Tuesday, August 8, 2023
UMHS, Mayo Clinic, University, Student, Southeastern United States, University of Puerto Rico, Medical Sciences Campus, Doctor, Physician, Private practice, Basic research, Hospital, Dream, MD, Patient, UPR, Faculty, ARP, University of Medicine and Health Sciences, Clinical professor, Next Generation, Achievement Medal, Psychiatry, Nursing

NEW YORK,  Aug. 8, 2023 /PRNewswire-PRWeb/ -- The University of Medicine and Health Sciences, (UMHS), a small, mission-driven medical school with a commitment to student support and a legacy of successful residency placements in the United States, Canada, and Puerto Rico, has published the recording of a recent panel discussion, "Pathways to Practicing Medicine in Puerto Rico." The event was hosted by Earl Mainer, UMHS senior associate director of admissions for the Southeastern United States and Puerto Rico, and featured a diverse panel of students, alumni, and practicing physicians to share their experiences, including: Andy Adler, a current UMHS student from Puerto Rico; Dr. Carlos Villanueva Soto, a recent graduate who placed into a highly competitive internal medicine residency at the University of Puerto Rico; Dr. Anelyn Martinez Rodriguez, a 2019 UMHS graduate and current psychiatry resident at San Juan VA Medical Center: and Dr. Eric Adler, a UMHS parent and an esteemed doctor in private practice in Puerto Rico. The panelists addressed common questions from prospective students and their families when evaluating an international medical school – including what it was like to move to St. Kitts, advice for matching into top residency programs, and what it's like to practice medicine in Puerto Rico. A recording of the event has been posted to the UMHS YouTube Live Events & Webinars page.

Key Points: 
  • A recording of the event has been posted to the UMHS YouTube Live Events & Webinars page.
  • "UMHS has been gaining momentum in Puerto Rico as students and their families look for the best options for earning an MD.
  • UMHS was founded by pioneers in medical education to help people get the best training and become medical doctors."
  • Past events include:
    Links to view all past discussions may be found by visiting the UMHS live events and webinars page.

Kineta Appoints Internationally-Renowned Clinical Immuno-oncology Experts to its Scientific Advisory Board

Retrieved on: 
Wednesday, March 1, 2023
Netherlands Cancer Institute, Immunotherapy, Cancer, Prostate cancer, DNA, University, Principal, Basic research, SAB, VISTA, Stomach cancer, Associate, Core, Fred Hutchinson Cancer Research Center, Research, University of Washington School of Medicine, Gastrointestinal cancer, Pacific Northwest, United States Department of Defense, National Cancer Institute, Biomarker, LAPS, Knight Cancer Institute, Patient, Esophageal cancer, Trial of the century, IDeA Networks of Biomedical Research Excellence, Cell, Clinical Cancer Research, OHSU, Ponce Health Sciences University, AACR, Oregon Health & Science University, United States Air Force Scientific Advisory Board, Oregon Health and Science University Center for Women's Health, Medical director, Development of the human body, ASCO, Gastrointestinal tract, Prostate, Medical device, Medical imaging, Kineta

to the company’s immuno-oncology focused Scientific Advisory Board (SAB).

Key Points: 
  • to the company’s immuno-oncology focused Scientific Advisory Board (SAB).
  • Dr. Chalabi and Dr. Yu will join Kineta’s SAB that includes Lisa Coussens, Ph.D., Michael Curran, Ph.D. and Patricia LoRusso, D.O.
  • “We are delighted to have Dr. Chalabi and Dr. Yu join Kineta's Scientific Advisory Board,” stated Thierry Guillaudeux, Ph.D., Chief Scientific Officer of Kineta.
  • “These experts will greatly complement our existing SAB and guide the company as we advance clinical development of KVA12123 in patients with advanced solid tumors.”
    Myriam Chalabi, M.D.

Youmans and Winn Neurological Surgery. 4 - Volume Set. Edition No. 8: The Latest Information on the Fast-Moving Field of Neurosurgery - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 7, 2022
Surgery, Health, Neuroimaging, Degenerative disease, Epilepsy, University of Iowa, Icahn School of Medicine at Mount Sinai, Precision medicine, Columbia University, Hofstra University, Basic research, Intracranial aneurysm, Spina bifida, Diffusion, Augmented reality, AI, Rehabilitation, Pregnancy, Patient, Multimedia, Deep brain stimulation, University, Brain, Ebook, Weill Cornell Medicine, Tribhuvan University Teaching Hospital, Medical imaging, Book, Spine, Neurosurgery

Widely regarded as the definitive reference in the field, Youmans and Winn Neurological Surgeryoffers unparalleled, multimedia coverage of the entirety of this complex specialty.

Key Points: 
  • Widely regarded as the definitive reference in the field, Youmans and Winn Neurological Surgeryoffers unparalleled, multimedia coverage of the entirety of this complex specialty.
  • An extensive video library contains stunning anatomy videos and videos demonstrating intraoperative procedures with more than 800 videos in all.
  • Each section contains a chapter providing an overview from experienced Section Editors, including a report on ongoing controversies within that subspecialty.
  • Your enhanced eBook allows you to access all of the text, figures, and references from the book on a variety of devices.

Basic Research Earns NSF/ANSI 455-2 Dietary Supplement GMP Certification

Retrieved on: 
Wednesday, December 14, 2022
Water, Certification, Food, Environment, Life, Basic research, Research, Food safety, DNA, Basic, GLP, GMP, NSF, SALT, American Health, ANSI, Water quality, Safety, Education, Health, Dietary supplement, Pharmaceutical industry, Operation

SALT LAKE CITY, Dec. 14, 2022 /PRNewswire/ -- The Basic Research manufacturing facility in Salt Lake City, Utah, was recently added to NSF's NSF/ANSI 455-2 Dietary Supplements Good Manufacturing Practice (GMP) certification. Earning GMP certification from NSF verifies that a manufacturing facility has the proper methods, equipment, facilities, and controls in place to produce dietary supplement products.

Key Points: 
  • Earning GMP certification from NSF verifies that a manufacturing facility has the proper methods, equipment, facilities, and controls in place to produce dietary supplement products.
  • Basic Research was founded in 1992 by three partners who wanted to revolutionize the dietary supplement industry, focusing on real science and research.
  • "We are very proud to earn GMP certification and are committed to continuing the practices that led us to this achievement."
  • "We're very pleased to grant NSF/ANSI 455 GMP certification to this Basic Research manufacturing facility."

NextCure Appoints Dr. Lisa M. Coussens to Scientific Advisory Board

Retrieved on: 
Thursday, October 27, 2022
Cell, University, American Association for Cancer Research, History, Associate, University of California, San Francisco, Development, Doctor of Philosophy, Society for Immunotherapy of Cancer, Nasdaq, Form 10-Q, Cancer, Forward-looking statement, Coronavirus Scientific Advisory Board (Turkey), National Center for Advancing Translational Sciences, Knight Cancer Institute, Basic research, Research, Patient, Society, Oregon Health & Science University, Leadership, American Association, Form 10-K, GLOBE, Ponce Health Sciences University, Marketing, Association, Hope, Academy, Sale, Immunotherapy, Pharmaceutical industry, Science

BELTSVILLE, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the appointment of Lisa M. Coussens, PhD, FAACR, to its Scientific Advisory Board.

Key Points: 
  • BELTSVILLE, Md., Oct. 27, 2022 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases, today announced the appointment of Lisa M. Coussens, PhD, FAACR, to its Scientific Advisory Board.
  • We are delighted to have Dr. Coussens join our Scientific Advisory Board, where she will leverage her exceptional experience in immuno-oncology said Solomon Langermann, PhD, NextCures chief scientific officer.
  • Dr. Coussens received her PhD from the University of California, Los Angeles, and carried out her post-doctoral work at the University of California, San Francisco.
  • NextCure is a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases.

Innovative, World Renowned Breast Cancer Experts to Receive Highest Honor from Susan G. Komen® as Recipients of 2022 Brinker Awards for Scientific Distinction

Retrieved on: 
Monday, October 10, 2022
Quality of life, SAN, Genetics, Tamoxifen, HIV disease progression rates, Disease, Medicine, Government, Woman, Science, Komen, Patient, Drug resistance, Research, Komen Brinker Award for Scientific Distinction, Pittsburgh, Breast cancer, Gene expression, Metastasis, Senior, University, Doctor of Philosophy, Health, Contact, Mission, Salk Institute for Biological Studies, Clinical research, FRCSC, FACS, FDA, Vanderbilt University Medical Center, Medical imaging, Dietary supplement, Pharmaceutical industry, Birth control, Basic research, MD

SAN ANTONIO, Oct. 10, 2022 /PRNewswire/ -- Susan G. Komen®, the world's leading breast cancer organization, named Geoffrey M. Wahl, PhD, and Norman Wolmark, MD, FACS, FRCSC, two leading breast cancer researchers, as recipients of this year's Brinker Awards, Komen's highest scientific honor.

Key Points: 
  • SAN ANTONIO, Oct. 10, 2022 /PRNewswire/ -- Susan G. Komen , the world's leading breast cancer organization, named Geoffrey M. Wahl, PhD, and Norman Wolmark, MD, FACS, FRCSC, two leading breast cancer researchers, as recipients of this year's Brinker Awards , Komen's highest scientific honor.
  • Established by Komen in 1992, the Brinker Awards for Scientific Distinction are the marquee scientific awards for honoring leading scientists who have made the most significant advances in breast cancer research and medicine.
  • Komen is the leading breast cancer research organization that has invested nearly $1.1 billion in breast cancer research, making it the largest funder of breast cancer research outside of the U.S. government.
  • Susan G. Komen is the world's leading nonprofit breast cancer organization, working to save lives and end breast cancer forever.

Manuscript for Improving Cancer Scientist and Patient Advocate Relationships Published

Retrieved on: 
Thursday, June 30, 2022
Baylor University, Baylor College of Medicine, Patient, Science, Breast cancer, Research, Huntsman Cancer Institute, Cancer, Goal, Professor, Hope, Basic research, Odds, Breast, University, Doctor of Philosophy, Quality of life, Friends, Solution, GRASP, Metastatic breast cancer, Manuscript, Friends of Cancer Research, Conference, Dietary supplement, Pharmaceutical industry, Medicine

HOUSTON, June 30, 2022 /PRNewswire/ -- Theresa's Research Foundation is excited to announce a new manuscript titled " Improving the Odds Together: A Framework for Breast Cancer Research Scientists to Include Patient Advocates in their Research " published today in npj Breast.

Key Points: 
  • HOUSTON, June 30, 2022 /PRNewswire/ -- Theresa's Research Foundation is excited to announce a new manuscript titled " Improving the Odds Together: A Framework for Breast Cancer Research Scientists to Include Patient Advocates in their Research " published today in npj Breast.
  • An appreciation for the value of including the patient advocate voice in cancer research has increased in recent years, however, basic research scientists are often uncertain about how to establish or maintain relationships with advocates.
  • "When scientists partner with patient advocates, real experiences of people living with cancer inform the work at every step, rather than being an afterthought.
  • Our hope is that the findings in the manuscript will encourage more basic research scientists to work with patient advocates to improve cancer research and patient outcomes," said Hillary Stires, PhD, Science Policy Analyst at Friends of Cancer Research.